CReATe Author Series: Ep. 3 - Dr. Michael Benatar and Neurofilament Biomarkers for ALS
22 dic 2021 ·
36 min. 32 sec.
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
Dr. Michael Benatar is the Walter Bradley Chair in ALS Research, a Professor of Neurology at the University of Miami Miller School of Medicine and the Principal Investigator of the...
mostra di più
Dr. Michael Benatar is the Walter Bradley Chair in ALS Research, a Professor of Neurology at the University of Miami Miller School of Medicine and the Principal Investigator of the CReATe Consortium. In this interview, he will discuss the CReATe Consortium’s recent paper titled "Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS". The interview highlights the specific ways in which validated biomarkers could benefit therapeutic development for ALS.
mostra meno
Commenti
Bill 3
2 anni fa
Sorry, it enter to soon. It sounds very simple and without risk, simply draw blood. but... it needs to be adapted. but 20 years of testing and talking about it...
Bill 3
2 anni fa
This apears to be wonderful news as a bio market and to evaluate treatmenst, but is is 10 or 20 years into the future until it is used?
Informazioni
| Autore | CReATe Consortium |
| Organizzazione | CReATe Consortium |
| Sito | - |
| Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
